Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
make more than 100%. For example, the Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH ) share price has soared 170% in the last three years. That sort of return is as solid as granite. Also pleasing for shareholders was the 25% gain in the last three months. Since it's been a strong week for Amphastar Pharmaceuticals shareholders, let's have a look at trend of the longer term fundamentals. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). Amphastar Pharmaceuticals was able to grow its EPS at 150% per year over three years, sending the share price higher. The average annual share price increase of 39% is actually lower than the EPS growth. So one could reasonably conclude that the market has cooled on the stock. The company's earnings per share (over ti
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma Sep. 06, 2024 8:39 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare ConferenceAccesswire
AMPH
Earnings
- 8/7/24 - Beat
AMPH
Sec Filings
- 9/17/24 - Form 4
- 9/16/24 - Form 4
- 9/6/24 - Form 4
- AMPH's page on the SEC website